ArticleBrain communications2026
Comprehensive profiling of paediatric chordoma: poorly differentiated and conventional subtypes.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chordoma in children is rare and inadequately characterized. This study aims to provide a comprehensive characterization of the clinicopathological and (epi)genetic features of chordomas in children, particularly the poorly differentiated chordomas (PDC). We established a cohort of seven PDCs and 28 conventional chordomas (CC). Besides characterizing the clinical and histopathological features, we performed comprehensive immunohistochemical staining for markers enabling diagnosis of chordoma and members of the sonic hedgehog signalling pathway. Using DNA methylation analysis, we characterized the molecular subtypes among chordomas in children and the SMARCB1 (INI1)-deficient tumours, which was further complemented by fluorescence in situ hybridization and targeted exome sequencing. Paediatric patients with PDC showed poorer prognosis compared with paediatric patients with CC. PDC tumours occurred more frequently in younger children and typically located at the clivus. Histologically, PDC tumours exhibited large polygonal/epithelioid cells or chubby spindle cells, with positive staining for cytokeratins and brachyury, but loss of expression of SMARCB1 (INI1) protein, and a high Ki-67 index. PDC samples showed promiscuous staining of sonic hedgehog pathway members, which contrasts the homogenous staining of sonic hedgehog pathway members in CC samples. Unsupervised hierarchical clustering and t-distributed stochastic neighbour embedding analyses of DNA methylation data showed that paediatric PDCs formed a distinct methylation cluster in comparison with the samples of CC, atypical teratoid/rhabdoid tumours and bone fide extracranial proximal epithelioid sarcoma. Whereas PDCs harboured relatively stable karyotype, frequent chromosomal gains or losses were observed in CCs. Mutational profiling identified different sets of genes in PDCs versus CCs. Loss of SMARCB1 (INI1) expression in PDCs was predominantly due to locus deletion. In summary, our findings support the differential diagnosis between paediatric PDC and CC. Further, our findings suggest that besides distinct methylome profiles, paediatric PDC and CC are likely driven by distinct pathogenic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.